DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of ‘pan-negative’-type lung adenocarcinomas
暂无分享,去创建一个
T. Kohno | Teruhiko Yoshida | H. Asamura | Y. Kanai | K. Tsuta | Mao Fujimoto | Eri Arai | Yoriko Takahashi | Ying Tian | K. Hamada | Shun‐ichi Watanabe | Shun-ichi Watanabe | Shun-Ichi Watanabe
[1] Teruhiko Yoshida,et al. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis , 2020, Epigenetics.
[2] P. Padma,et al. Epigenetic alterations in cancer. , 2020, Frontiers in bioscience.
[3] H. Popper,et al. Adenocarcinoma , 2020, Essentials of Diagnostic Pathology.
[4] Y. Kanai,et al. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer , 2019, Carcinogenesis.
[5] M. Noguchi,et al. DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma , 2019, Oncotarget.
[6] V. Cardaci,et al. Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer. , 2019, Recent patents on anti-cancer drug discovery.
[7] Shicheng Guo,et al. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma , 2018, Cell Death & Disease.
[8] Y. Totoki,et al. Epigenome mapping of human normal purified hepatocytes: personal epigenome variation and genome-epigenome correlation. , 2018, Epigenomics.
[9] R. Fry,et al. Environmental Influences on the Epigenome: Exposure- Associated DNA Methylation in Human Populations. , 2018, Annual review of public health.
[10] Y. Miyagi,et al. The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses , 2018, Pathology international.
[11] T. Graham,et al. An evolutionary perspective on field cancerization , 2017, Nature Reviews Cancer.
[12] I. Wistuba,et al. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas , 2017, Oncotarget.
[13] Y. Kanai,et al. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis , 2017, Carcinogenesis.
[14] T. Kohno,et al. Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens , 2016, Carcinogenesis.
[15] T. Kohno,et al. Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy , 2017, Surgery Today.
[16] Peter A. Jones,et al. Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.
[17] Peter A. Jones,et al. Epigenetic Determinants of Cancer. , 2016, Cold Spring Harbor perspectives in biology.
[18] Vessela Kristensen,et al. Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis , 2015, Molecular oncology.
[19] 尾原 健太郎. Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs : a single-institutional methylome analysis using 1007 tissue specimens(審査報告) , 2016 .
[20] David Petersen,et al. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] Teruhiko Yoshida,et al. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas , 2015, International journal of cancer.
[22] Takanori Kanai,et al. Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.
[23] Teruhiko Yoshida,et al. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome , 2014, Carcinogenesis.
[24] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[25] Y. Kanai,et al. Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium , 2014, Front. Genet..
[26] T. Betsuyaku,et al. Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease , 2013, International journal of cancer.
[27] Koji Tsuta,et al. DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma , 2013, PloS one.
[28] Y. Kanai,et al. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas , 2012, Carcinogenesis.
[29] K. D. Sørensen,et al. Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis , 2012, International journal of cancer.
[30] Xiao Zhang,et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.
[31] K. Gunderson,et al. Genome-wide DNA methylation profiling using Infinium® assay. , 2009, Epigenomics.
[32] C. Ambrosone,et al. Molecular epidemiology to better predict lung cancer risk. , 2008, Clinical lung cancer.
[33] B. Reiser,et al. Estimation of the Youden Index and its Associated Cutoff Point , 2005, Biometrical journal. Biometrische Zeitschrift.
[34] S. Hirohashi,et al. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. , 1997, Cancer research.
[35] J. Minna,et al. NCI‐navy medical oncology branch cell line data base , 1996, Journal of cellular biochemistry. Supplement.
[36] K. Fujise,et al. Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. , 1990, Hepato-gastroenterology.
[37] K. Tanaka,et al. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. , 1979, British Journal of Cancer.
[38] S. Aaronson,et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. , 1973, Journal of the National Cancer Institute.